Amarin Announces ADS Ratio Change for Market Compliance
Amarin Corporation plc (NASDAQ: AMRN) has made an important announcement regarding its American Depositary Shares (ADS). The company will implement a crucial change in the ratio of its ADSs, which will officially take effect soon. This proactive measure aims to increase the per-share market price of Amarin's ADSs in compliance with Nasdaq's requirements.
The Details of the Ratio Change
The transition involves shifting from a one-for-one ratio to a one-for-twenty ratio. This means that one ADS will now represent twenty ordinary shares. This decision is primarily driven by the need to meet Nasdaq's minimum bid price requirement of $1.00 per share. Maintaining this listing is essential for Amarin as it seeks to provide sustained value to its shareholders.
Aiming for Increased Valuation
One of the key motivations behind this ratio change is to enhance the trading price of the ADS following the change. However, it is vital to note that despite this adjustment, Amarin cannot guarantee that the trading price will align with expectations. Shareholders are advised to remain informed and monitor the situation closely.
Impact on Ordinary Shares
Despite the significant ratio adjustment, the ordinary shares of Amarin will remain unaffected. This separation ensures that the core value and integrity of the ordinary shares are maintained while adjustments to the ADS structure are being made. Investors are encouraged to continue their engagement with Amarin’s market performances.
Amarin’s Commitment to Innovation
At the heart of Amarin’s operations lies a strong commitment to pioneering advancements in cardiovascular disease management. The company is dedicated to improving scientific understanding of cardiovascular risks that extend beyond traditional treatments. With an international presence, including offices in strategic locations and partnerships around the globe, Amarin is poised for continued growth and innovation.
Engaging with Investors
Amarin places great importance on keeping its investors informed. The investor relations section on the corporate website hosts a range of resources, including updates on the recent ratio change and its implications. This commitment to transparency plays a crucial role in building trust and confidence among stakeholders.
Frequently Asked Questions
What is the reason behind the ADS ratio change?
The primary motivation for the ratio change is to increase the per-share market price of the ADS to meet Nasdaq's minimum bid price requirement.
Will the ordinary shares be affected by this change?
No, the ordinary shares will remain unaffected by the change in the ADS ratio.
How can investors get more information regarding this change?
Investors can find additional details about the ADS ratio change in the investor relations section of Amarin’s corporate website.
What are the potential impacts on ADS trading post-change?
While the change aims to enhance the trading price, there is no guarantee that the price will meet expectations following the adjustment.
What does Amarin focus on as a company?
Amarin is focused on innovating treatments for cardiovascular diseases, emphasizing the importance of addressing risks that persist beyond conventional therapies.
